MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-10-2025
RadNet Operating Expenses 2011-2026 | RDNT
Annual Operating Expenses RadNet
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.73 B | 1.52 B | 1.38 B | 1.24 B | 1.06 B | 80.6 M | 72.9 M | 66.8 M | 66.6 M | 60.6 M | 59.3 M | 58.9 M | 57.7 M | 93.6 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 1.73 B | 57.7 M | 539 M |
Quarterly Operating Expenses RadNet
| 2025-Q3 | 2025-Q2 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 495 M | 467 M | - | 427 M | 425 M | - | 359 M | 379 M | 384 M | - | 343 M | 335 M | 343 M | - | 300 M | 306 M | 304 M | - | 269 M | 216 M | 290 M | 278 M | 276 M | 267 M | 264 M | 258 M | 226 M | 229 M | 232 M | 217 M | 217 M | 216 M | 222 M | 210 M | 212 M | 210 M | 213 M | 205 M | 191 M | 191 M | 183 M | 171 M | 169 M | 163 M | 161 M | 165 M | 167 M | 164 M | 165 M | 153 M | 147 M | 152 M | 151 M | 140 M | 132 M | 133 M | 130 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 495 M | 130 M | 243 M |
Operating Expenses of other stocks in the Diagnostics research industry
| Issuer | Operating Expenses | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Akumin
AKU
|
778 M | - | -17.87 % | $ 25.9 M |  Canada |
|
Centogene N.V.
CNTG
|
58 M | - | -6.23 % | $ 30.6 M |  Germany |
 |
Accelerate Diagnostics
AXDX
|
77.2 M | - | -61.36 % | $ 2.46 M |  USA |
 |
Brainsway Ltd.
BWAY
|
29.2 M | $ 19.02 | 0.21 % | $ 99.4 M |  Israel |
 |
Co-Diagnostics
CODX
|
45.3 M | $ 0.17 | -6.7 % | $ 4.99 M | USA |
 |
Burning Rock Biotech Limited
BNR
|
726 M | $ 20.15 | -2.3 % | $ 217 M |  China |
 |
Danaher Corporation
DHR
|
6.71 B | $ 228.92 | -0.76 % | $ 167 B | USA |
 |
Biocept
BIOC
|
21.6 M | - | -13.05 % | $ 7.29 M | USA |
 |
Chembio Diagnostics
CEMI
|
28.5 M | - | 0.22 % | $ 16.8 M | USA |
 |
DexCom
DXCM
|
1.69 B | $ 66.37 | -1.03 % | $ 25.6 B | USA |
 |
BioNano Genomics
BNGO
|
41.3 M | $ 1.53 | 2.0 % | $ 1.94 M | USA |
 |
Castle Biosciences
CSTL
|
59.5 M | $ 38.9 | -1.04 % | $ 1.08 B | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
59.4 M | - | - | $ 562 M |  Britain |
 |
DermTech
DMTK
|
104 M | - | -11.32 % | $ 2.94 M | USA |
 |
DarioHealth Corp.
DRIO
|
62.2 M | $ 11.38 | 6.36 % | $ 323 M | Israel |
 |
IQVIA Holdings
IQV
|
2.94 B | $ 225.41 | -1.0 % | $ 40.9 B | USA |
 |
Enzo Biochem
ENZ
|
47.4 M | - | -8.98 % | $ 14.8 K | USA |
 |
Exact Sciences Corporation
EXAS
|
2.98 B | $ 101.56 | -0.33 % | $ 18.8 B | USA |
 |
Fulgent Genetics
FLGT
|
181 M | $ 26.27 | -0.83 % | $ 794 M | USA |
 |
Global Cord Blood Corporation
CO
|
451 M | - | - | $ 399 M | China |
 |
Fluidigm Corporation
FLDM
|
134 M | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
5.91 M | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
983 M | - | 0.12 % | $ 80.1 M | China |
 |
PRA Health Sciences, Inc.
PRAH
|
585 M | - | - | $ 10.7 B | USA |
 |
Myriad Genetics
MYGN
|
709 M | $ 6.15 | -0.32 % | $ 557 M | USA |
 |
CareDx, Inc
CDNA
|
484 M | $ 18.84 | -1.21 % | $ 1.01 B | USA |
 |
NeoGenomics
NEO
|
382 M | $ 11.76 | -3.84 % | $ 1.49 B | USA |
 |
Celcuity
CELC
|
113 M | $ 99.74 | -0.18 % | $ 3.93 B | USA |
 |
National Research Corporation
NRC
|
38.5 M | $ 18.77 | 0.64 % | $ 461 M | USA |
 |
Anixa Biosciences
ANIX
|
9.98 M | $ 3.12 | - | $ 99.5 K | USA |
 |
Precipio
PRPO
|
13.6 M | $ 22.98 | -1.84 % | $ 29.8 M | USA |
 |
Personalis
PSNL
|
44.5 M | $ 7.96 | -0.13 % | $ 472 M | USA |
 |
Heska Corporation
HSKA
|
131 M | - | - | $ 1.31 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
24.1 M | - | -20.0 % | $ 1.06 M | USA |
 |
Guardant Health
GH
|
226 M | $ 102.14 | 1.53 % | $ 12.5 B | USA |
 |
Aspira Women's Health
AWH
|
37.1 M | - | -6.19 % | $ 10.5 M | USA |
 |
ENDRA Life Sciences
NDRA
|
10.8 M | $ 4.53 | -4.83 % | $ 2.43 M | USA |
 |
Soleno Therapeutics
SLNO
|
188 M | $ 46.3 | 0.02 % | $ 1.86 B | USA |
 |
Illumina
ILMN
|
3.69 B | $ 131.16 | -1.2 % | $ 20.9 B | USA |
 |
Charles River Laboratories International
CRL
|
607 M | $ 199.48 | -1.24 % | $ 10.2 B | USA |
 |
Thermo Fisher Scientific
TMO
|
7.15 B | $ 579.45 | -0.69 % | $ 221 B | USA |
 |
Trinity Biotech plc
TRIB
|
28.3 M | $ 0.79 | -3.54 % | $ 61.9 M |  Irlanda |
 |
Quest Diagnostics Incorporated
DGX
|
1.46 B | $ 173.53 | -1.12 % | $ 19.3 B | USA |
|
Biodesix
BDSX
|
106 M | $ 6.8 | 1.19 % | $ 882 M | USA |
 |
Motus GI Holdings
MOTS
|
18.6 M | - | -34.28 % | $ 263 K | Israel |
 |
Laboratory Corporation of America Holdings
LH
|
1.87 B | $ 250.88 | -0.87 % | $ 21 B | USA |
 |
Twist Bioscience Corporation
TWST
|
116 M | $ 31.72 | -1.34 % | $ 1.9 B | USA |
 |
ICON Public Limited Company
ICLR
|
408 M | $ 182.22 | -0.43 % | $ 15 B | Irlanda |
 |
IDEXX Laboratories
IDXX
|
1.25 B | $ 676.53 | -0.85 % | $ 55.8 B | USA |
 |
Lantheus Holdings
LNTH
|
123 M | $ 66.55 | -0.91 % | $ 4.61 B | USA |